Market
- 2023/03/21
- 【Market】(The Japan Times)
2008 bank crisis survivors remember how fast dominoes can fall - 2023/03/21
- 【Market】(The Japan Times)
Safe-havens and risk assets both rise as banking woes shift Fed expectations - 2023/03/20
- 【Market】(The Japan Times)
Asian markets downcast despite UBS takeover of Credit Suisse - 2023/03/17
- 【Market】(The Japan Times)
‘Seek-and-destroy’ markets pile pressure on global central banks - 2023/03/16
- 【Market】(The Japan Times)
From Credit Suisse to Silicon Valley Bank, lenders’ woes abroad rattle Asian markets - 2023/03/14
- 【Market】(The Japan Times)
SVB crisis drives concern over Japanese banks’ exposure to U.S. bonds - 2023/03/07
- 【Market】(The Japan Times)
Yen has scope to jump around 60% if BOJ normalizes and Fed eases - 2023/02/10
- 【Market】(The Japan Times)
Japan’s bond bears delighted by government’s BOJ picks - 2023/02/09
- 【Market】(The Japan Times)
Japan investors sold record foreign debt in 2022 as hedging costs rose - 2023/02/07
- 【Market】(The Japan Times)
Japan intervened in forex markets twice in October to support yen, report shows - 2023/02/05
- 【Market】(The Japan Times)
Inside the 19-hour meltdown that junked Adani’s share sale - 2023/02/03
- 【Market】(The Japan Times)
Japan’s GPIF, the world’s biggest pension fund, posts longest loss in 20 years - 2023/02/02
- 【Market】(The Japan Times)
Japan agricultural bank Nochu readies global return after U.K. selloff - 2023/01/22
- 【Market】(The Japan Times)
Bullish calls mount as Asian stocks go on a tear in the new year - 2023/01/19
- 【Market】(The Japan Times)
Funds plan relentless pressure on BOJ as they eye full surrender - 2023/01/19
- 【Market】(The Japan Times)
Funds plan relentless pressure on BOJ as they eye full surrender - 2023/01/17
- 【Market】(The Japan Times)
Japan pushes global counterparts to regulate cryptocurrencies like banks - 2023/01/12
- 【Market】(The Japan Times)
BOJ may end yield-curve control next quarter - 2023/01/12
- 【Market】(The Japan Times)
BOJ may end yield-curve control next quarter - 2023/01/10
- 【Market】(The Japan Times)
Eisai shares jump after FDA approves Alzheimer’s drug lecanemab